You are here: Home » Current Affairs » Coronavirus » News
India coronavirus update: Covid-19 caseload rises to 7,370,468
Business Standard

Remdesivir, HCQ don't aid much in recovery of Covid-19 patients: WHO trials

While Gilead calls for review, the findings can have significant impact on the growing demand of remdesivir

Topics
Coronavirus Vaccine | Coronavirus Tests | Coronavirus

Sohini Das  |  Mumbai 



remdesivir, coronavirus, drugs, covid, pharma
The demand for the drug went up rapidly, creating a supply shortage in India.

Gilead’s remdesivir has little or no impact on Covid-19 patients' length of hospital stay, initiation of ventilation, or chances of survival, a clinical trial by the World Health Organization (WHO) has found.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Fri, October 16 2020. 10:31 IST

RECOMMENDED FOR YOU